97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
Showing 1 to 4 of 4 diseases
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000017844 | 2015/06/22 | 22/06/2015 | Antibiotic combination therapy for ulcerative colitis | Antibiotic combination therapy for ulcerative colitis - Antibiotic combination therapy for ulcerative colitis Antibiotic combination therapy for ulcerative colitis - Antibiotic combination therapy for ulcerativ ... | ulcerative colitis | amoxicillin, tetracycline, and metronidazole | Shiga University of Medical Science | NULL | Complete: follow-up complete | 20years-old | 80years-old | Male and Female | 20 | Not selected | Japan |
| 2 | JPRN-UMIN000009811 | 2013/01/23 | 21/01/2013 | Comparison of randomized trials of antibiotic combination therapies for patients with ulcerative colitis Comparison of randomized trials of antibiotic combination therapies for patients with ulcerative col ... | Comparison of randomized trials of antibiotic combination therapies for patients with ulcerative colitis - Antibiotics trials for ulcerative colitis Comparison of randomized trials of antibiotic combination therapies for patients with ulcerative col ... | Ulcerative colitis | One group is to receive two-week combination therapy consisting of amoxicillin (Sawacillin) 500 mg t.i.d, tetracycline (Acromycin) 500 mg t.i.d, and metronidazole (Flagyl) 250 mg t.i.d. with an inhibitor of gastric acid secretion. Patients are to be followed for 3 months (first endpoint). Another group will receive two week combination therapy consisting of amoxicillin (Sawacillin) 500 mg t.i.d, fosfomycin (Fosmicin) 1000mg t.i.d, and metrozole (Flagyl) 250 mg t.i.d, with an inhibitor of gastric acid secretion. Patients are to be followed for 3 months. One group is to receive two-week combination therapy consisting of amoxicillin(Sawacillin) 500 mg t. ... | Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine | NULL | Complete: follow-up complete | 16years-old | 75years-old | Male and Female | 40 | Phase 3 | Japan |
| 3 | JPRN-UMIN000048515 | 2008/10/01 | 31/07/2022 | A comparative trial between antibiotic combination therapy and steroid therapy for ulcerative colitis patients A comparative trial between antibiotic combination therapy and steroid therapy for ulcerative coliti ... | A comparative trial between antibiotic combination therapy and steroid therapy for ulcerative colitis patients - A comparative trial between antibiotic combination therapy and steroid therapy for ulcerative colitis patients A comparative trial between antibiotic combination therapy and steroid therapy for ulcerative coliti ... | Ulcerative colitis | 14 days oral intake of amoxicillin 1500 mg/day, tetracycline 1500 mg/day and metronidazole 750 mg/day | Juntendo University | NULL | Complete: follow-up continuing | 18years-old | Not applicable | Male and Female | 350 | Not selected | Japan |
| 4 | JPRN-C000000078 | 2003/10/01 | 26/08/2005 | Antibiotic Combination Therapy in Patients with Active Refractory Ulcerative Colitis: A Prospective Randomized Placebo-controlled Multicenter Study Antibiotic Combination Therapy in Patients with Active Refractory Ulcerative Colitis: A Prospective ... | Antibiotic Combination Therapy in Patients with Active Refractory Ulcerative Colitis: A Prospective Randomized Placebo-controlled Multicenter Study - Antibiotic Combination Therapy in Patients with Active Refractory Ulcerative Colitis Antibiotic Combination Therapy in Patients with Active Refractory Ulcerative Colitis: A Prospective ... | Ulcerative Colitis | Patients in the treatment group receive an antibiotic combination consisting of amoxicillin 500mg tid, tetracycline 500mg tid, and metronidazole 250mg tid for two weeks. patients in the control group recieve three kinds of placebo contained sugar. Patients in the treatment group receive an antibiotic combination consisting of amoxicillin500mg tid ... | Japan UC Antibiotics-therapy Study Group(JUCASG) | Nihon University,Iwate Medical University, Kyoto Central HospitalYamagata Central HospitalOita University, Tokyo Medical UniversityToyama Medical & Pharmaceutical University, Showa University Nihon University,Iwate Medical University, Kyoto Central HospitalYamagata Central HospitalOita Unive ... | Complete: follow-up complete | 15years-old | 70years-old | Male and Female | 210 | Phase 2 | Japan |